MindMed Announces Voluntary Delisting from Cboe Canada

Contributed by: Business Wire

Logo

Tags

Science

Neurology

Biotechnology

Research

Pharmaceutical

Health

Mental Health

Clinical Trials

Cboe Canada Delisting

More Like This

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement

MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering

MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference

MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update

MindMed Announces New Employee Inducement Grants

MindMed to Participate in Upcoming Investor Conferences